Jack's story
Jack was diagnosed with stage 4 high-risk neuroblastoma in February 2024 when he was five years old. His mum, Sarah, shares his story.
CCLG Research Talks: How does neuroblastoma genetics help us treat patients?
We talk to Professor Deborah Tweddle about how understanding more about genetics has helped treatment for neuroblastoma.
New research to uncover best treatment options for relapsed and refractory neuroblastoma
CCLG: The Children & Young People’s Cancer Association is proud to have funded a new research project investigating the latest experimental treatments for hard-to-treat neuroblastoma.
Spotlight on our childhood cancer experts in Southampton
In the UK and Ireland, over 100 childhood cancer researchers have been funded through CCLG. But what are they working on? Let's take a trip to Southampton to find out...
How the variability of neuroblastoma makes it harder to cure
Cancer cells can have differences in how they survive, respond to treatment, and behave. This variability can help cancer cells survive and adapt, but it also makes doctors’ jobs much harder.
The 'glittering' idea that could help children with high-risk neuroblastoma
Children with aggressive neuroblastoma often can't be treated with standard treatments like radiotherapy and chemotherapy - but what about new treatments like immunotherapy?